[Applications and safety of modern antidepressants in patients with liver diseases].
In the study we subjected to analysis literature referred to safety of SSRI's, venlafaxine, milnacipran, mirtazapine, nefazodone and trazodone in patients with the diagnosis of depression and concomitant hepatopathy.
Dubarek
Wit
W
Z Wojewódzkiego Szpitala Neuropsychiatrycznego w Lublińcu.
Kucia
Krzysztof
K
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects* / Q000627:therapeutic use; D003511:Cyclohexanols / Q000009:adverse effects / Q000627:therapeutic use; D003521:Cyclopropanes / Q000009:adverse effects / Q000627:therapeutic use; D003866:Depressive Disorder / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D008107:Liver Diseases / Q000150:complications* / Q000378:metabolism; D008803:Mianserin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D000078764:Milnacipran; D000078785:Mirtazapine; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D010879:Piperazines; D012307:Risk Factors; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D014230:Triazoles / Q000009:adverse effects / Q000627:therapeutic use; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D003511:Cyclohexanols; D003521:Cyclopropanes; D008803:Mianserin; D000078764:Milnacipran; D000078785:Mirtazapine; D008996:Monoamine Oxidase Inhibitors; D010879:Piperazines; D017367:Selective Serotonin Reuptake Inhibitors; D014230:Triazoles; D000069470:Venlafaxine Hydrochloride; C051752:nefazodone